皮下注射-话题@MedSci

#皮下注射#

50篇内容 | 2239人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1372248, encodeId=db0713e224811, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle= Anesthesiology：皮下注射硝酸甘油用于小儿患者桡动脉置管, objectType=article, longId=194989, objectId=87171949890c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87171949890c, replyNumber=0, likeNumber=60, createdTime=2020-06-01, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87171949890c, moduleTitle= Anesthesiology：皮下注射硝酸甘油用于小儿患者桡动脉置管, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87171949890c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372247, encodeId=0b0013e22476b, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=JACC：皮下注射selatogrel可以抑制急性心梗患者血小板聚集, objectType=article, longId=194822, objectId=ef121948222f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef121948222f, replyNumber=0, likeNumber=61, createdTime=2020-05-29, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef121948222f, moduleTitle=JACC：皮下注射selatogrel可以抑制急性心梗患者血小板聚集, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef121948222f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372246, encodeId=2ccc13e22466f, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=FDA批准重磅抗癌靶向药达雷妥尤单抗皮下注射制剂！给药由3小时缩短至5分钟！, objectType=article, longId=193564, objectId=d732193564a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d732193564a3, replyNumber=0, likeNumber=51, createdTime=2020-05-07, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d732193564a3, moduleTitle=FDA批准重磅抗癌靶向药达雷妥尤单抗皮下注射制剂！给药由3小时缩短至5分钟！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d732193564a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372245, encodeId=cd2b13e2245be, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, objectType=article, longId=192943, objectId=28a119294391, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28a119294391, replyNumber=0, likeNumber=58, createdTime=2020-04-26, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28a119294391, moduleTitle=Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28a119294391)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372244, encodeId=d23b13e22444d, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Gastroenterology：Vedolizumab皮下注射在溃疡性结肠炎患者中的疗效和安全性, objectType=article, longId=188609, objectId=03481886094b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03481886094b, replyNumber=0, likeNumber=65, createdTime=2020-02-24, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03481886094b, moduleTitle=Gastroenterology：Vedolizumab皮下注射在溃疡性结肠炎患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03481886094b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372243, encodeId=88fd13e224325, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Enhanze药物输送技术：评估固定剂量皮下注射帕妥珠单抗和曲妥珠单抗的III期试验取得阳性结果, objectType=article, longId=179522, objectId=8c931e952273, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c931e952273, replyNumber=0, likeNumber=65, createdTime=2019-09-17, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c931e952273, moduleTitle=Enhanze药物输送技术：评估固定剂量皮下注射帕妥珠单抗和曲妥珠单抗的III期试验取得阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c931e952273)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372242, encodeId=001b13e22422c, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Blood：皮下注射达雷木单抗治疗复发性/难治性多发性骨髓瘤, objectType=article, longId=174848, objectId=d8fa1e484829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8fa1e484829, replyNumber=0, likeNumber=60, createdTime=2019-07-06, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8fa1e484829, moduleTitle=Blood：皮下注射达雷木单抗治疗复发性/难治性多发性骨髓瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8fa1e484829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372241, encodeId=bf4413e22419c, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市, objectType=article, longId=167787, objectId=f96e16e787c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f96e16e787c7, replyNumber=0, likeNumber=86, createdTime=2019-06-08, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f96e16e787c7, moduleTitle=西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f96e16e787c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372240, encodeId=78e413e2240d3, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=美国FDA接受Takeda申请皮下注射维多珠单抗，用于溃疡性结肠炎的维持治疗, objectType=article, longId=165924, objectId=85db165924d9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85db165924d9, replyNumber=0, likeNumber=60, createdTime=2019-05-14, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85db165924d9, moduleTitle=美国FDA接受Takeda申请皮下注射维多珠单抗，用于溃疡性结肠炎的维持治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85db165924d9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372239, encodeId=f2b313e22398d, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=皮下注射误入血管，被染红的药水推还是不推？, objectType=article, longId=154848, objectId=201a154848b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=201a154848b8, replyNumber=0, likeNumber=79, createdTime=2018-12-02, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=201a154848b8, moduleTitle=皮下注射误入血管，被染红的药水推还是不推？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=201a154848b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372238, encodeId=b1d113e223869, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Health Technol Assess：1型糖尿病儿童和青少年：持续皮下注射胰岛素vs每日多次注射, objectType=article, longId=149867, objectId=92e014986eb0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92e014986eb0, replyNumber=0, likeNumber=58, createdTime=2018-09-30, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92e014986eb0, moduleTitle=Health Technol Assess：1型糖尿病儿童和青少年：持续皮下注射胰岛素vs每日多次注射, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92e014986eb0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372237, encodeId=3be313e22376e, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=西安杨森上市国内**每月皮下注射一次抗风湿生物制剂欣普尼, objectType=article, longId=141331, objectId=b2131413318b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2131413318b, replyNumber=0, likeNumber=65, createdTime=2018-06-24, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2131413318b, moduleTitle=西安杨森上市国内**每月皮下注射一次抗风湿生物制剂欣普尼, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2131413318b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372236, encodeId=201e13e223660, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Stroke：缺血性卒中皮下注射白细胞介素-1受体拮抗剂疗效分析, objectType=article, longId=133244, objectId=8b8a13324461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b8a13324461, replyNumber=0, likeNumber=55, createdTime=2018-03-25, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b8a13324461, moduleTitle=Stroke：缺血性卒中皮下注射白细胞介素-1受体拮抗剂疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b8a13324461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372235, encodeId=c19f13e223550, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=皮下注射精蛋白生物合成人胰岛素引起注射部位银屑病, objectType=article, longId=127749, objectId=fca812e749bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fca812e749bc, replyNumber=0, likeNumber=58, createdTime=2018-01-27, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fca812e749bc, moduleTitle=皮下注射精蛋白生物合成人胰岛素引起注射部位银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fca812e749bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372234, encodeId=199d13e2234f2, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=JACC Heart Failure ：心衰加重急诊患者——静脉vs皮下注射呋塞米, objectType=article, longId=126952, objectId=3567126952c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3567126952c8, replyNumber=0, likeNumber=76, createdTime=2018-01-21, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3567126952c8, moduleTitle=JACC Heart Failure ：心衰加重急诊患者——静脉vs皮下注射呋塞米, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3567126952c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372233, encodeId=e3fb13e223363, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=西安杨森抗风湿免疫病皮下注射生物制剂欣普尼®在中国获批, objectType=article, longId=125572, objectId=5dcf1255e2c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5dcf1255e2c7, replyNumber=0, likeNumber=64, createdTime=2018-01-06, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5dcf1255e2c7, moduleTitle=西安杨森抗风湿免疫病皮下注射生物制剂欣普尼®在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5dcf1255e2c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372232, encodeId=95f613e223232, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Am J Rhinol Allergy：经历皮下注射免疫疗法和舌下免疫疗法病人生活质量结果研究, objectType=article, longId=112970, objectId=8b411129e0f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b411129e0f7, replyNumber=0, likeNumber=71, createdTime=2017-09-17, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b411129e0f7, moduleTitle=Am J Rhinol Allergy：经历皮下注射免疫疗法和舌下免疫疗法病人生活质量结果研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b411129e0f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372231, encodeId=55ad13e2231c5, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Diabetic Med：皮下注射胰岛素（CSII）治疗效果如何？, objectType=article, longId=111587, objectId=92c111158e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c111158e42, replyNumber=0, likeNumber=64, createdTime=2017-09-02, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c111158e42, moduleTitle=Diabetic Med：皮下注射胰岛素（CSII）治疗效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92c111158e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372230, encodeId=749713e2230f3, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=皮下注射胰岛素，需要捏起皮肤吗？, objectType=article, longId=108491, objectId=0b0b1084916e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b0b1084916e, replyNumber=0, likeNumber=65, createdTime=2017-08-12, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b0b1084916e, moduleTitle=皮下注射胰岛素，需要捏起皮肤吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b0b1084916e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1372229, encodeId=b40513e222940, content=<a href='/topic/show?id=1a6de1930e8' target=_blank style='color:#2F92EE;'>#皮下注射#</a>, objectTitle=Arthritis Rheumatol：皮下注射贝利木单抗治疗系统性红斑狼疮中的疗效和安全性, objectType=article, longId=97732, objectId=0b079e73206, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b079e73206, replyNumber=0, likeNumber=59, createdTime=2017-05-04, rootId=0, userName=zhlpower, userId=c838337, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b079e73206, moduleTitle=Arthritis Rheumatol：皮下注射贝利木单抗治疗系统性红斑狼疮中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b079e73206)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

皮下注射

2020-05-29

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Anesthesiology：皮下注射硝酸甘油用于小儿患者桡动脉置管

2020-06-01

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

JACC：皮下注射selatogrel可以抑制急性心梗患者血小板聚集

2020-05-29

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

FDA批准重磅抗癌靶向药达雷妥尤单抗皮下注射制剂！给药由3小时缩短至5分钟！

2020-05-07

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Lancet haematol：3期试验：达雷木单抗皮下注射和静脉注射治疗复发性/难治性多发性骨髓瘤的效果和安全性对比

2020-04-26

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Gastroenterology：Vedolizumab皮下注射在溃疡性结肠炎患者中的疗效和安全性

2020-02-24

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Enhanze药物输送技术：评估固定剂量皮下注射帕妥珠单抗和曲妥珠单抗的III期试验取得阳性结果

2019-09-17

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Blood：皮下注射达雷木单抗治疗复发性/难治性多发性骨髓瘤

2019-07-06

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

西安杨森宣布国内每三月皮下注射一次治疗银屑病生物制剂喜达诺®上市

2019-06-08

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

美国FDA接受Takeda申请皮下注射维多珠单抗，用于溃疡性结肠炎的维持治疗

2019-05-14

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

皮下注射误入血管，被染红的药水推还是不推？

2018-12-02

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Health Technol Assess：1型糖尿病儿童和青少年：持续皮下注射胰岛素vs每日多次注射

2018-09-30

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

西安杨森上市国内**每月皮下注射一次抗风湿生物制剂欣普尼

2018-06-24

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Stroke：缺血性卒中皮下注射白细胞介素-1受体拮抗剂疗效分析

2018-03-25

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

皮下注射精蛋白生物合成人胰岛素引起注射部位银屑病

2018-01-27

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

JACC Heart Failure ：心衰加重急诊患者——静脉vs皮下注射呋塞米

2018-01-21

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

西安杨森抗风湿免疫病皮下注射生物制剂欣普尼®在中国获批

2018-01-06

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Am J Rhinol Allergy：经历皮下注射免疫疗法和舌下免疫疗法病人生活质量结果研究

2017-09-17

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Diabetic Med：皮下注射胰岛素（CSII）治疗效果如何？

2017-09-02

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

皮下注射胰岛素，需要捏起皮肤吗？

2017-08-12

zhlpower (审核中...)

前往app查看评论内容

#皮下注射#

Arthritis Rheumatol：皮下注射贝利木单抗治疗系统性红斑狼疮中的疗效和安全性

2017-05-04

科室
- - 订阅+
  - 更多科室
工具
服务